Shaoqin Qiu

Active 2020–2020

5
Papers
34,396
Citations
5
h-index
5
i10-index

Citations

Citations per year for Shaoqin Qiu1982: 2 citations1991: 1 citations1994: 1 citations2001: 1 citations2004: 1 citations2005: 1 citations2007: 2 citations2010: 1 citations2011: 2 citations2012: 1 citations2019: 7 citations2020: 7,445 citations2021: 3,481 citations2022: 1,117 citations2023: 291 citations2024: 281 citations2025: 55 citations2026: 1 citations1983–1990: no citations, so these years are not shown1992–1993: no citations, so these years are not shown1995–2000: no citations, so these years are not shown2002–2003: no citations, so these years are not shown2006: no citations, so this year is not shown2008–2009: no citations, so these years are not shown2013–2018: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,532 citing papers, 17.5% of this breakdownChina: 2,790 citing papers, 13.8% of this breakdownItaly: 1,354 citing papers, 6.7% of this breakdownUnited Kingdom: 1,213 citing papers, 6% of this breakdownIndia: 727 citing papers, 3.6% of this breakdownSpain: 699 citing papers, 3.5% of this breakdownGermany: 623 citing papers, 3.1% of this breakdownFrance: 561 citing papers, 2.8% of this breakdownCanada: 527 citing papers, 2.6% of this breakdownBrazil: 503 citing papers, 2.5% of this breakdownIran: 453 citing papers, 2.2% of this breakdownAustralia: 418 citing papers, 2.1% of this breakdown
0%17.5%Other 33.6%

Fields

  • Medicine81.5%
  • Mathematics4.4%
  • Biochemistry, Genetics and Molecular Biology2.9%
  • Psychology2.1%
  • Immunology and Microbiology2.1%
  • Neuroscience1.3%
  • Other5.7%

Topics

  • COVID-19 Clinical Research Studies21.5%
  • Long-Term Effects of COVID-1910.5%
  • SARS-CoV-2 and COVID-19 Research9.3%
  • COVID-19 and healthcare impacts5.1%
  • COVID-19 epidemiological studies2.8%
  • COVID-19 and Mental Health2.4%
  • Other48.4%

Coauthors

All papers

Open in search
  1. Clinical Characteristics of Coronavirus Disease 2019 in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gang Li, Zhijian Zheng, Shaoqin Qiu, Jie Luo, Chang-jiang Ye, Shaoyong Zhu, Nanshan Zhong - New England Journal of Medicine 2020 cited by 31,158

  2. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yimin Li, Jianxing He, Jing Li, Shiyue Li, Nanshan Zhong - Journal of Allergy and Clinical Immunology 2020 cited by 411

  3. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Feng Ye, Jinping Zheng, Nuofu Zhang, Yimin Li, Jianxing He, Shiyue Li, Nanshan Zhong - CHEST Journal 2020 cited by 692

  4. Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peng Peng, Jianming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhijian Zheng, Shaoqin Qiu, Jie Luo, Chang-jiang Ye, Shaoyong Zhu, Linling Cheng, Feng Ye, Shiyue Li, Jin-ping Zheng, Nuofu Zhang, Nanshan Zhong, Jianxing He - medRxiv 2020 cited by 650

  5. Clinical characteristics of 2019 novel coronavirus infection in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gang Li, Zhijian Zheng, Shaoqin Qiu, Jie Luo, Chang-jiang Ye, Shaoyong Zhu, Nanshan Zhong - medRxiv 2020 cited by 1,485

All 5 papers shown.